Tolemy Bio secures a £1.2m pre-seed round led by Norrsken Evolve for software that connects fragmented cell biology data into one workspace

Tolemy Bio develops software for biopharma teams working with cell therapies and therapeutic proteins. Its platform, Orbit, brings together experimental data from lab tools, spreadsheets, notebooks and shared files to help scientists interpret cell behaviour and optimise experiments.